Dereplication of Natural Product Antifungals via Liquid Chromatography–Tandem Mass Spectrometry and Chemical Genomics
Molecules · 28.12.2024 · 30 (1) · 77
DOI: 10.3390/molecules30010077 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 28.12.2024. Verfasst von Nathaniel J Brittin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Sciences Division, University of Wisconsin-Madison, Madison, WI 53705, USA. Hauptthemen laut MEDLINE: Biological Products, Antifungal Agents, Genomics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, NIH HHS.
Abstract (Originalsprache)
Recently expanded reports of multidrug-resistant fungal infections underscore the need to develop new and more efficient methods for antifungal drug discovery. A ubiquitous problem in natural product drug discovery campaigns is the rediscovery of known compounds or their relatives; accordingly, we have integrated Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS) for structural dereplication and Yeast Chemical Genomics for bioprocess evaluation into a screening platform to identify such compounds early in the screening process. We identified 450 fractions inhibiting Candida albicans and the resistant strains of C. auris and C. glabrata among more than 40,000 natural product fractions. LC-MS/MS and chemical genomics were then used to identify those with known chemistry and mechanisms of action. The parallel deployment of these orthogonal methods improved the detection of unwanted compound classes over the methods applied individually.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Sciences Division, University of Wisconsin-Madison, Madison, WI 53705, USA.
- Lachman Institute for Pharmaceutical Development, University of Wisconsin-Madison, Madison, WI 53705, USA.
- Small Molecule Screening Facility, UW Carbone Cancer Center, Madison, WI 53792, USA.
- Department of Biochemistry and Biomedical Sciences, M.G. DeGroote Institute for Infectious Disease Research, David Braley Centre for Antibiotic Discovery, McMaster University, Hamilton, ON L8S 4L8, Canada.
- Department of Bacteriology, University of Wisconsin-Madison, Madison, WI 53706, USA.
- Department of Medical Microbiology and Immunology, School of Medicine and Public Health, University of Wisconsin, Madison, WI 53706, USA.
ORCID-Profile: Nathaniel J Brittin, David J Aceti, Spencer S Ericksen, Scott R Rajski, Tim S Bugni
Förderung
- NCI NIH HHS
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health (NIAID)
Zitieren
APA
Brittin, N. J., Aceti, D. J., Braun, D. R., Anderson, J. M., Ericksen, S. S., Rajski, S. R., Currie, C. R., Andes, D. R., & Bugni, T. S. (2024). Dereplication of Natural Product Antifungals via Liquid Chromatography–Tandem Mass Spectrometry and Chemical Genomics. Molecules, 30(1), 77. https://doi.org/10.3390/molecules30010077
Vancouver
Brittin NJ, Aceti DJ, Braun DR, Anderson JM, Ericksen SS, Rajski SR, et al. Dereplication of Natural Product Antifungals via Liquid Chromatography–Tandem Mass Spectrometry and Chemical Genomics. Molecules. 2024;30(1):77. doi:10.3390/molecules30010077
BibTeX
@article{Brittin2024,
author = {Brittin, Nathaniel J and Aceti, David J and Braun, Doug R and Anderson, Josephine M and Ericksen, Spencer S and Rajski, Scott R and Currie, Cameron R and Andes, David R and Bugni, Tim S},
title = {Dereplication of Natural Product Antifungals via Liquid Chromatography–Tandem Mass Spectrometry and Chemical Genomics},
journal = {Molecules},
year = {2024},
volume = {30},
number = {1},
pages = {77},
doi = {10.3390/molecules30010077}
}
EUVIMED